Clinical Translation and the Commercialisation of Nanomedicine University of Oxford

Overview

What you will study

The scientists and entrepreneurs who survive and prosper amidst such remarkable impact and growth are those who have the best comprehension of the pathway to market. Ensuring your innovative nanotechnologies have the optimal opportunity to fulfil their potential requires an understanding of the regulatory, financial, clinical and commercial challenges faced. The Clinical Translation and the Commercialisation of Nanomedicine course offered by University of Oxford aims to provide this understanding. The course will encourage students and researchers to think about the entire pathway of testing and commercialising their scientific ideas, and to introduce them to issues surrounding regulation, intellectual property and financing. Lecturers with expertise and experience in each of these key spheres will provide important insights, whilst case-studies will be lead by entrepreneur scientists who have successfully navigated the pathway.

The course will provide students with the opportunity to gain knowledge and understanding of:

• The pre-clinical, clinical and regulatory pathways required for approval

• Market and intellectual property assessment

• Mechanisms and sources of finance

• Notable case studies